Vasoactive intestinal polypeptide stimulation of cyclic AMP formation in rat central nervous system. 1980

T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka

Vasoactive intestinal polypeptide (VIP) stimulated cyclic AMP formation in the anterior pituitary, hypothalamus, pons and cerebral medulla of rat in vitro. The concentration of VIP above 10(-7) M significantly raised cyclic AMP level of these tissues with dose-dependency and the maximum stimulation of cyclic AMP formation was obtained at 5 min incubation. This stimulatory effect of VIP was not inhibited by propranolol or somatostatin. However, no enhancement of hormone release from the anterior pituitary or hypothalamus into the incubation medium by VIP was observed. These results suggest that VIP may act through adenylate cyclase in specific areas of rat central nervous system independent of beta-adrenergic receptor, but it may not necessarily be related to hormone release from the anterior pituitary or hypothalamus.

UI MeSH Term Description Entries
D007031 Hypothalamus Ventral part of the DIENCEPHALON extending from the region of the OPTIC CHIASM to the caudal border of the MAMMILLARY BODIES and forming the inferior and lateral walls of the THIRD VENTRICLE. Lamina Terminalis,Preoptico-Hypothalamic Area,Area, Preoptico-Hypothalamic,Areas, Preoptico-Hypothalamic,Preoptico Hypothalamic Area,Preoptico-Hypothalamic Areas
D008297 Male Males
D010903 Pituitary Gland, Anterior The anterior glandular lobe of the pituitary gland, also known as the adenohypophysis. It secretes the ADENOHYPOPHYSEAL HORMONES that regulate vital functions such as GROWTH; METABOLISM; and REPRODUCTION. Adenohypophysis,Anterior Lobe of Pituitary,Anterior Pituitary Gland,Lobus Anterior,Pars Distalis of Pituitary,Adenohypophyses,Anterior Pituitary Glands,Anterior, Lobus,Anteriors, Lobus,Lobus Anteriors,Pituitary Anterior Lobe,Pituitary Glands, Anterior,Pituitary Pars Distalis
D011433 Propranolol A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs. Dexpropranolol,AY-20694,Anaprilin,Anapriline,Avlocardyl,Betadren,Dociton,Inderal,Obsidan,Obzidan,Propanolol,Propranolol Hydrochloride,Rexigen,AY 20694,AY20694,Hydrochloride, Propranolol
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005768 Gastrointestinal Hormones HORMONES secreted by the gastrointestinal mucosa that affect the timing or the quality of secretion of digestive enzymes, and regulate the motor activity of the digestive system organs. Enteric Hormone,Enteric Hormones,Gastrointestinal Hormone,Intestinal Hormone,Intestinal Hormones,Hormone, Enteric,Hormone, Gastrointestinal,Hormone, Intestinal,Hormones, Enteric,Hormones, Gastrointestinal,Hormones, Intestinal
D000242 Cyclic AMP An adenine nucleotide containing one phosphate group which is esterified to both the 3'- and 5'-positions of the sugar moiety. It is a second messenger and a key intracellular regulator, functioning as a mediator of activity for a number of hormones, including epinephrine, glucagon, and ACTH. Adenosine Cyclic 3',5'-Monophosphate,Adenosine Cyclic 3,5 Monophosphate,Adenosine Cyclic Monophosphate,Adenosine Cyclic-3',5'-Monophosphate,Cyclic AMP, (R)-Isomer,Cyclic AMP, Disodium Salt,Cyclic AMP, Monoammonium Salt,Cyclic AMP, Monopotassium Salt,Cyclic AMP, Monosodium Salt,Cyclic AMP, Sodium Salt,3',5'-Monophosphate, Adenosine Cyclic,AMP, Cyclic,Adenosine Cyclic 3',5' Monophosphate,Cyclic 3',5'-Monophosphate, Adenosine,Cyclic Monophosphate, Adenosine,Cyclic-3',5'-Monophosphate, Adenosine,Monophosphate, Adenosine Cyclic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013004 Somatostatin A 14-amino acid peptide named for its ability to inhibit pituitary GROWTH HORMONE release, also called somatotropin release-inhibiting factor. It is expressed in the central and peripheral nervous systems, the gut, and other organs. SRIF can also inhibit the release of THYROID-STIMULATING HORMONE; PROLACTIN; INSULIN; and GLUCAGON besides acting as a neurotransmitter and neuromodulator. In a number of species including humans, there is an additional form of somatostatin, SRIF-28 with a 14-amino acid extension at the N-terminal. Cyclic Somatostatin,Somatostatin-14,Somatotropin Release-Inhibiting Hormone,SRIH-14,Somatofalk,Somatostatin, Cyclic,Somatotropin Release-Inhibiting Factor,Stilamin,Somatostatin 14,Somatotropin Release Inhibiting Factor,Somatotropin Release Inhibiting Hormone

Related Publications

T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
January 1983, Postepy higieny i medycyny doswiadczalnej,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
December 1978, Journal of neurochemistry,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
March 1985, Brain research,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
October 1982, Journal of neurochemistry,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
February 1985, European journal of pharmacology,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
December 1971, Annals of the New York Academy of Sciences,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
January 1994, Visual neuroscience,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
January 1988, Archives internationales de pharmacodynamie et de therapie,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
July 1994, Biochemistry and molecular biology international,
T Kaneko, and S Nakaya, and S Saito, and N Yanaihara, and H Oka
November 1985, Biochimica et biophysica acta,
Copied contents to your clipboard!